Mycophenolate mofetil and Glucagon drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mycophenolate mofetil (mycophenolate mofetil) and Glucagon (glucagon hydrochloride). Common drug interactions include hypotension among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Mycophenolate mofetil and Glucagon. It is created by eHealthMe based on reports of 36 people who take the same drugs from the FDA, and is updated regularly.

What is Mycophenolate mofetil?

Mycophenolate mofetil has active ingredients of mycophenolate mofetil. It is often used in myasthenia gravis. eHealthMe is studying from 93,460 Mycophenolate mofetil users. Check the latest studies of Mycophenolate mofetil.

What is Glucagon?

Glucagon has active ingredients of glucagon hydrochloride. eHealthMe is studying from 4,297 Glucagon users. Check the latest studies of Glucagon.

On Jul, 14, 2026

36 people who take Mycophenolate mofetil and Glucagon together, and have interactions are studied.

Mycophenolate mofetil and Glucagon drug interactions.

What are the common drug interactions of Mycophenolate Mofetil and Glucagon, by gender? *:

female:

Hypotension (abnormally low blood pressure)
Immunosuppression
Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
Pulmonary embolism (blockage of the main artery of the lung)
Ventricular fibrillation (abnormally irregular heart rhythm)
Thrombocytopenia (decrease of platelets in blood)
Blood glucose fluctuation
Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
Cytomegalovirus infection
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)

male:

Asthenia (weakness)
Anxiety
Arrhythmia (irregular heartbeat)
Blood glucose increased
Bowel movement irregularity
Cardiac arrest
Chronic kidney disease
Cough
Decreased appetite
Failure to thrive (inadequate weight gain and physical growth in children)

What are the common drug interactions of Mycophenolate Mofetil and Glucagon, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Posterior reversible encephalopathy syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss)
Diarrhoea
Fatigue (feeling of tiredness)
Headache (pain in head)
Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
Pneumonia
Respiratory syncytial virus infection (viral disease of respiratory system)
Transplant rejection (a transplant material is not worked)

20-29:

n/a

30-39:

n/a

40-49:

Abdominal pain
Anxiety
Asthenia (weakness)
Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
Diarrhoea
Emotional distress
Extremity contracture (permanent shortening of a muscle or joint of arms and legs)
Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
Gait disturbance
General physical health deterioration (weak health status)

50-59:

Arthralgia (joint pain)
Asthenia (weakness)
Atrophy (wasting away of a part of the body)
Back pain
Balance disorder
Blindness
Confusional state
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
Diarrhoea

60+:

Nausea (feeling of having an urge to vomit)
Diarrhoea
Fall
Vomiting
Aggression
Anaemia (lack of blood)
Anxiety
Arrhythmia (irregular heartbeat)
Asthenia (weakness)
Bowel movement irregularity

What are the existing conditions these people have? *

Pain: 6 people, 16.67%
Immunodeficiency Disorders: 6 people, 16.67%
High Blood Pressure: 4 people, 11.11%
Hypoglycemia (low blood sugar): 4 people, 11.11%
Dermatomyositis (inflammation of the skin and underlying muscle tissue, typically occurring as an autoimmune condition or associated with internal cancer): 3 people, 8.33%
Diabetes: 3 people, 8.33%
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 3 people, 8.33%
Urination - Excessive At Night: 2 people, 5.56%
Hypokalemia (low potassium): 2 people, 5.56%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Mycophenolate mofetil and Glucagon?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously